The goal of this proposal is to determine the biochemical mechanisms responsible for lung reperfusion injury. HYPOTHESES: 1. Xanthine oxidase (XO) is critically important in initiating lung reperfusion injury and changes in its gene expression, processing and translation of mRNA, and stability of the final protein product are important determinants of susceptibility to reperfusion injury. 2. Propagation of lung reperfusion injury is fostered by disturbances in intracellular energy metabolism created during ischemia and persisting through the initial stages of reperfusion. 3. Nitric oxide (NO.) plays a central role in ameliorating lung reperfusion injury. RESEARCH PLAN: The project will investigate the molecular, biochemical and physiologic basis for lung reperfusion injury.
The first aim will be to assess the molecular and cellular regulation of the xanthine: acceptor oxidoreductase system (XDH/XO) and to establish the relationship between alterations in enzyme expression and susceptibility to reperfusion injury. A hierarchy of methods ranging from in vitro to in situ to in vivo will be employed to determine the importance of cytokines and 02 tension as modulators of transcriptional regulation, protein modification and enzyme activity of XDH/XO, and susceptibility to reperfusion injury.
The second aim will be to characterize changes in intracellular energy metabolism during ischemia and reperfusion. A comprehensive assessment will characterize changes in adenine nucleotides and their catabolites during ischemia and reperfusion.
The third aim will determine the role played by NO. in lung reperfusion injury. Our preliminary experiments indicate that L-arginine which enhances NO. production, but not Nw-nitro-L-arginine, a competitive antagonist which blocks NO. production, prevents lung reperfusion injury. Studies will examine the mechanism of this protective effect focusing in particular on the ability of NO. to activate guanylate cyclase, to inhibit Fe-S enzymes and to prevent hydroxyl radical (HO.) formation catalyzed by heme bound iron by occupying the catalytic iron coordination site. Studies will also determine the importance of cytokines and 02 tension as modulators of transcriptional regulation and enzyme activity of NO synthase. SIGNIFICANCE: The proposed research will provide a better understanding of lung reperfusion injury so that methods of preventing or interrupting the process can be designed.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL040665-08
Application #
2219688
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1988-09-01
Project End
1997-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
8
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Lin, Junji; Xu, Ping; LaVallee, Patricia et al. (2008) Identification of proteins binding to E-Box/Ku86 sites and function of the tumor suppressor SAFB1 in transcriptional regulation of the human xanthine oxidoreductase gene. J Biol Chem 283:29681-9
Xu, Ping; LaVallee, Patricia A; Lin, Jun J et al. (2004) Characterization of proteins binding to E-box/Ku86 sites and function of Ku86 in transcriptional regulation of the human xanthine oxidoreductase gene. J Biol Chem 279:16057-63
Brar, Sukhdev S; Kennedy, Thomas P; Sturrock, Anne B et al. (2002) An NAD(P)H oxidase regulates growth and transcription in melanoma cells. Am J Physiol Cell Physiol 282:C1212-24
Ghio, Andrew J; Kennedy, Thomas P; Stonehuerner, Jacqueline et al. (2002) Iron regulates xanthine oxidase activity in the lung. Am J Physiol Lung Cell Mol Physiol 283:L563-72
Brar, S S; Kennedy, T P; Whorton, A R et al. (2001) Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells. Am J Physiol Cell Physiol 280:C659-76
Xu, P; LaVallee, P; Hoidal, J R (2000) Repressed expression of the human xanthine oxidoreductase gene. E-box and TATA-like elements restrict ground state transcriptional activity. J Biol Chem 275:5918-26
Fryer, A; Huang, Y C; Rao, G et al. (1997) Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung. J Pharmacol Exp Ther 282:208-19
Poss, W B; Huecksteadt, T P; Panus, P C et al. (1996) Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. Am J Physiol 270:L941-6
Cannon, G W; Openshaw, S J; Hibbs Jr, J B et al. (1996) Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 39:1677-84
Xu, P; Huecksteadt, T P; Hoidal, J R (1996) Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH). Genomics 34:173-80

Showing the most recent 10 out of 16 publications